Cardio-Phoenix News & Updates
Unraveling diagnostic co-morbidity makeup of each HF category as characteristically derived by ECG- and ECHO-findings
Background Echocardiography (ECHO) is not widely available in primary care, the key structural (chamber enlargements) and functional abnormality are not easily available precluding the ability…
Pacemaker patient assessment with CHART
Situation Female patient with a previous history of carcinoma and mildly decreased systolic function due to cardiotoxicity. She had a previous heart trauma and a…
HETT Show 2022 – Interview with Marc
The HETT show 2022 has been successfully finished for Cardio-Phoenix Company. We spoke with Marc, CEO and Founder of Cardio-Phoenix, about the experience and expectations after…
Cardio-Heart at HETT Show 2022
Our team at Cardio-Phoenix is excited to announce that we will be exhibiting at the Healthcare Excellence Through Technology (HETT Show) on 27-28 September 2022.…
Cardio-Phoenix secures Angel funding for early heart disease-predicting AI
London, Lisbon, Toronto, September 2022. Cardio-Phoenix’s AI assesses novel bio-signals of the heart to predict 14 significant cardiac abnormalities typically diagnosed only by…
Improving early identification of cardiovascular problems at the point-of-care
Background Patient 00 has an artificial valve or prosthesis. The patient is under cardiology observation. However, the next cardiology appointment is 6 months…
Categories
- Announcement (22)
- Events (9)
- Insights (10)
- Publications (10)
- Use Case (8)
